| Evaluating the Potential for Biomarker Use in CT Screening |
Hilary Robbins |
International Agency for Research on Cancer (IARC) |
PLCO |
Feb 20, 2019 |
PLCO-456 |
| Self-reported dietary intake and serum metabolite correlations |
Kaitlyn Mazzilli |
National Cancer Institute |
PLCO |
Feb 13, 2019 |
PLCO-454 |
| Ovarian cancer identification using machine learning techniques |
Julius Ting |
Asia Pacific University |
PLCO |
Feb 11, 2019 |
PLCO-452 |
| Feature Selection for Survival Analysis with Competing Risks using Deep Learning |
Mihaela van der Schaar |
University of California, Los Angeles |
PLCO |
Feb 11, 2019 |
PLCO-453 |
| Light at night and prostate cancer risk and progression |
Lorelei Mucci |
Harvard University |
PLCO |
Feb 11, 2019 |
PLCO-433 |
| The link between diabetes status and pancreatic Cancer survival |
Sabrina Benteftifa |
Independent |
PLCO |
Feb 1, 2019 |
PLCO-451 |
| Ovarian Cancer prediction using machine learning |
Apurva Katti |
Florida State University |
PLCO |
Jan 28, 2019 |
PLCO-448 |
| Body-mass index and mortality among US Latinos |
Amy Berrington de González |
National Cancer Institute |
PLCO |
Jan 28, 2019 |
PLCO-450 |
| Risk factor epidemiology of male breast cancer based on the PLCO trial |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Jan 24, 2019 |
PLCO-447 |
| Prediction of Colorectal Cancer Using Support Vector Machine Algorithm |
Bawer Berwary |
Van Yuzuncu Yil University |
PLCO |
Jan 17, 2019 |
PLCO-445 |
| PLCO risk assessment formula |
Aharona Shuali |
Nucleix |
PLCO |
Jan 15, 2019 |
PLCO-441 |
| Pre-diagnostic body mass index in relation to hormone receptor positive versus hormone receptor negative breast cancer incidence and mortality |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Dec 28, 2018 |
PLCO-432 |
| A Prospective Study of Inflammation-Based Markers for Lung Cancer Risk and Survival in African Americans |
Brid Ryan |
NCI |
PLCO |
Dec 21, 2018 |
2018-1020 |
| Genetic and environmental determinants of the oral microbiota |
Christian Abnet |
NCI/DCEG |
PLCO |
Dec 21, 2018 |
2018-1016 |
| A Prospective Investigation of Microbial Metabolites and Colorectal Cancer |
Erikka Loftfield |
National Cancer Instiute |
PLCO |
Dec 21, 2018 |
2018-1017 |
| Low dose aspirin use from SQX and risk of ovarian cancer |
Britton Trabert |
University of Utah/Huntsman Cancer Institute |
PLCO |
Dec 18, 2018 |
PLCO-431 |
| Updated data request: Ovarian cancer risk factors by histologic subtypes and development of an ovarian cancer risk prediction model in the Ovarian Cancer Cohort Consortium (OC3) |
Nicolas Wentzensen |
DCEG, NCI |
PLCO |
Dec 11, 2018 |
PLCO-429 |
| Quantifying risk of prostate cancer in men with inflammatory bowel disease. |
Shilajit Kundu |
Northwestern University Feinberg School of Medicine |
PLCO |
Dec 11, 2018 |
PLCO-428 |
| The association of dietary glycemic index and glycemic load on ovarian cancer incidence and survival in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort |
Jennifer Mongiovi |
University at Buffalo |
PLCO |
Dec 11, 2018 |
PLCO-427 |
| Diet, Metabolic Biomarkers and Lung Cancer Risk |
Martin Carl Tammemagi |
Brock University |
PLCO |
Nov 19, 2018 |
PLCO-418 |
